Company intelligence / Profile preview

Agteria Biotech

Ownership: Private
Development stage: Preclinical

Overview

Agteria Biotech has developed a novel, patent-pending small molecule feed additive that reduces enteric methane emissions from cattle by up to ~70%. The product has demonstrated high efficacy and safety in multiple in vivo trials with no adverse effects on animal health or behavior. The company recently raised significant seed funding to advance regulatory approvals and further studies. Their solution aims for global scalability at low cost, targeting integration into existing agricultural value chains to help reduce global greenhouse gas emissions by at least one percent by the year 2035[1][2][3][4][5][6].

Therapeutic areas: Other
Modalities: Small molecule feed additive (novel, patent-pending methane inhibitor)[1][4][6]
Industry: Agriculture & AgTech

Drug pipeline

1 asset

AB-01

Pre-clinical

Indications: Cattle methane emissions reduction

Partnerships

None specifically named with major pharma/biotech companies; strong investor partnerships include Norrsken Launcher, Industrifonden, Mudcake, and AgriZeroNZ[6].

Beyond the preview

Go deeper on Agteria Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agteria Biotech.

Explore the full profile